Drugs and Devices

FDA approves treatments for irritable bowel syndrome

On May 27, the U.S. Food and Drug Administration (FDA) approved Viberzi (eluxadoline) and Xifaxan (rifaximin) for irritable bowel syndrome with diarrhea in adult men and women. Read more.


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Shares